Skip to main content

Table 1 Patient Characteristics in the Training, Internal Test, and External Test Sets

From: Deep learning based on ultrasound images to predict platinum resistance in patients with epithelial ovarian cancer

Variables

Training set (n = 216)

P

Internal test set (n = 70)

P

External test set (n = 106)

P

Resistant (n = 64)

Sensitive (n = 152)

Resistant (n = 18)

Sensitive (n = 52)

Resistant (n = 39)

Sensitive (n = 67)

BMI, mean (SD)

24.12 (2.62)

23.77 (2.82)

0.494

24.11 (3.08)

24.16 (4.21)

0.962

24.07 (1.84)

23.67 (2.72)

0.716

Age, mean (SD), year

56.05 (7.92)

56.44 (8.32)

0.650

56.39 (7.39)

57.88 (7.19)

0.453

57.29 (8.13)

57.54 (8.29)

0.823

CA125, mean (SD), ng/ml

1592.48 (1351.93)

1440.51 (1243.02)

0.486

1327.58 (1437.53)

1223.59 (1113.01)

0.753

1337.68 (1303.16)

1204.37 (1058.11)

0.689

PFI, mean (SD), month

4.52 (1.79)

18.95 (13.02)

 <.001

4.39 (1.88)

21.52 (16.87)

 <.001

4.74 (1.72)

22.35 (14.36)

 <.001

Type of surgery, No. (%)

  

0.748

  

0.935

  

0.951

PDS

21 (32.81)

46 (30.26)

 

3 (16.67)

7 (13.46)

 

7 (17.95)

13 (19.40)

 

IDS

43 (67.19)

106 (69.74)

 

15 (83.33)

45 (86.54)

 

32 (82.05)

54 (80.60)

 

HIPEC, No. (%)

  

0.695

  

0.211

  

0.842

No

29 (45.31)

68 (44.74)

 

14 (77.78)

32 (61.54)

 

23 (58.97)

38 (56.72)

 

Yes

35 (54.69)

84 (55.26)

 

4 (22.22)

20 (38.46)

 

16 (41.03)

29 (43.28)

 

Histologic classification, n (%)

  

0.349

  

0.624

  

0.481

High grade serous carcinoma

59 (92.19)

121 (79.61)

 

16 (88.89)

45 (86.54)

 

34 (87.18)

57 (85.07)

 

Endometrioid carcinoma

0 (0.00)

6 (3.95)

 

0 (0.00)

1 (1.92)

 

0 (0.00)

2 (2.99)

 

Clear cell carcinoma

1 (1.56)

3 (1.97)

 

0 (0.00)

0 (0.00)

 

0 (0.00)

1 (1.49)

 

Mucinous carcinoma

0 (0.00)

2 (1.32)

 

0 (0.00)

1 (1.92)

 

1 (2.56)

0 (0.00)

 

Low grade serous carcinoma

4 (6.25)

20 (13.15)

 

2 (11.11)

5 (9.62)

 

4 (10.26)

7 (10.45)

 

FIGO stage, n (%)

  

0.858

  

0.820

  

0.871

II

4 (6.25)

6 (3.95)

 

1 (5.56)

2 (3.85)

 

1 (2.56)

2 (2.99)

 

III

54 (84.38)

127 (83.55)

 

15 (83.33)

47 (90.38)

 

33 (84.62)

54 (80.60)

 

IV

6 (9.37)

19 (12.50)

 

2 (11.11)

3 (5.77)

 

5 (12.82)

11 (16.42)

 
  1. BMI, body mass index; CA125, cancer antigen 125; PFI, platinum-free interval; HIPEC, hyperthermic intraperitoneal chemotherapy; FIGO, International Federation of Gynecology and Obstetrics; SD, standard deviation; PDS, primary debulking surgery; IDS, interval debulking surgery